Prevalence and persistence of depression in patients with implantable cardioverter defibrillator: A 2-year longitudinal study

PACE - Pacing and Clinical Electrophysiology

Volumn 33, Issue 12, 2010, Pages 1455-1461

  Suzuki, Tsuyoshi ^a   Shiga, Tsuyoshi ^a   Kuwahara, Kazue ^a   Kobayashi, Sayaka ^a   Suzuki, Shinichi ^b   Nishimura, Katsuji ^a   Suzuki, Atsushi ^a   Ejima, Koichiro ^a   Manaka, Tetsuyuki ^a   Shoda, Morio ^a   Ishigooka, Jun ^a   Kasanuki, Hiroshi ^b   Hagiwara, Nobuhisa ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b WASEDA UNIVERSITY   (Japan)

Author keywords

depression; implantable cardioverter defibrillator; shock

Indexed keywords

ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUESTIONNAIRE; SCORING SYSTEM;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; CARDIOMYOPATHIES; CORONARY ARTERY DISEASE; DEFIBRILLATORS, IMPLANTABLE; DEPRESSION; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; LONG QT SYNDROME; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; STROKE VOLUME; TREATMENT OUTCOME;

EID: 78650115474     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2010.02887.x     Document Type: Article

References (31)

1. Goldberger Z, Lampert R,. Implantable cardioverter-defibrillators. Expanding indications and technologies. JAMA 2006; 295: 809-818.
2. Sears SF, Todaro JF, Urizar G, Lewis TS, Sirois B, Wallace R, Sotile W, et al,. Assessing the psychosocial impact of the ICD: A national survey of implantable cardioverter defibrillator health care providers. Pacing Clin Electrophysiol 2000; 23: 939-945.
3. Sears SF, Conti JB,. Quality of life and psychological functioning of ICD patients. Heart 2002; 87: 488-493.
4. Thomas SA, Friedmann E, Kao CW, Inguito P, Metcalf M, Kelley FJ, Gottlieb SS,. Quality of life and psychological status of patients with implantable cardioverter defibrillators. Am J Crit Care 2006; 15: 389-398. (Pubitemid 44859179)
5. Jacq F, Foulldrin G, Savouré A, Anselme F, Baguelin-Pinaud A, Cribier A, Thibaut F,. A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients. Gen Hosp Psychiatry 2009; 31: 266-273.
6. Rozanski A, Blumenthal JA, Kaplan J,. Impact of psychological factors on the pathogenesis of cardiovascular disease and implication for therapy. Circulation 1999; 99: 2192-2217.
7. Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, Cuffe MS, Blazing MA, et al,. Relationship of depression to increase risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001; 161: 1849-1856.
8. Vaccarino V, Kasl SV, Abramson J, Krumholz HM,. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 2001; 38: 199-205.
9. Carney RM, Blumenthal JA, Catellier D, Freedland KE, Berkman LF, Watkins LL, Czajkowski SM, et al,. Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol 2003; 92: 1277-1281.
10. Whooley MA,. Depression and cardiovascular disease: healing the broken-hearted. JAMA 2006; 295: 2874-2881.
11. Luukinen H, Laippala P, Huikuri HV,. Depressive symptoms and the risk of sudden cardiac death among the elderly. Eur Heart J 2003; 24: 2021-2026.
12. Whang W, Kubzansky LD, Kawachi I, Rexrode KM, Kroenke CH, Glynn RJ, Garan H, et al,. Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol 2009; 53: 950-958.
13. Bilge AK, Ozben B, Demircan S, Cinar M, Yilmaz E, Adalet K,. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin Electrophysiol 2006; 29: 619-626.
14. Whang W, Albert CM, Sears SF, Lampert R, Conti JB, Wang PJ, Singh JP, et al,., for the TOVA Study Investigators. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol 2005; 45: 1090-1095.
15. Hegel MT, Griegel LE, Black C, Goulden L, Ozahowski T,. Anxiety and depression in patients receiving implanted cardioverter-defibrillators: a longitudinal investigation. Int J Psychiatry Med 1997; 27: 57-69.
16. Kamphuis HCM, De Leeuw JRJ, Derksen R, Hauer RNW, Winnubst JAM,. Implantable cardioverter defibrillator receipients: Quality of life in recipients with and without ICD shock delivery. Europace 2003; 5: 381-389.
17. Kapa S, Rotondi-Trevisan D, Mariano Z, Aves T, Irvine J, Dorian P, Hayes DL,. Psychopathology in patients with ICDs over time: Results of a prospective study. Pacing Clin Electrophysiol 2010; 33: 198-208.
18. Thomas SA, Friedmann E, Gottlieb SS, Liu F, Morton PG, Chapa DW, Lee HJ, et al,., on behalf of the Sudden Cardiac Death in Heart Failure Trial Investigators. Changes in psychosocial distress in outpatients with heart failure with implantable cardioverter defibrillators. Heart Lung 2009; 38: 109-120.
19. Zung WW,. A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 63-70.
20. Zung WW,. The differentiation of anxiety and depressive disorders: A biometric approach. Psychosomatics 1971; 12: 380-384.
21. Williams JW Jr, Noel PH, Cordes JA, Ramirez G, Piqnone M,. Is this patient clinically depressed? JAMA 2002; 287: 1160-1170.
22. Okimoto JT, Barnes RF, Veith RC, Baskind MA, Inui TS, Carter WB,. Screening for depression in geriatric medical patients. Am J Psychiatry 1982; 139: 799-802.
23. Passik SD, Kirsh KL, Donaghy KB, Theobald DE, Lundberg JC, Holtsclaw E, Dugan WM Jr,. An attempt to employ the Zung Self-Rating Depression Scale as a lab test to trigger follow-up in ambulatory oncology clinics: Criterion validity and detection. J Pain Symptom Manage 2001; 21: 273-281.
24. Raison CL, Borisov AS, Broadwell SD, Capuron L, Woolwine BJ, Jacobson IM, Nemeroff CB, et al,. Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry 2005; 66: 41-48.
25. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH,. Electrical storm in patients with transvenous implantable cardioverter- defibrillators: Incidence, management and prognostic implications. J Am Coll Cardiol 1998; 32: 1909-1915.
26. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ,. Depression in heart failure: A meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006; 48: 1527-1537.
27. Doris A, Ebmeier K, Shajahan P,. Depressive illness. Lancet 1999; 354: 1369-1375.
28. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, et al,. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCSR). JAMA 2003; 289: 3095-3105.
29. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, Kutalek SP, et al,., and the AVID Investigators. Quality of life in the antiarrhythmics versus implantable defibrillators trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002; 105: 589-594.
30. Herrmann C, Von Zur Mühen F, Schaumann A, Buss U, Kemper S, Wantzen C, Gonska BD,. Standardized assessment of psychological well-being and quality-of-life in patients with implantable defibrillators. Pacing Clin Electrophysiol 1997; 20 (Pt. I): 95-103.
31. Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, Newman D, et al,., for the CIDS Investigators. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002; 144: 282-289.